Metabolic HealthResearch PaperOpen Access

Blood Sugar Stress Ratio Predicts Chronic Disease Risk in Middle-Aged Adults

New biomarker identifies who's at highest risk for diabetes, hypertension, and liver disease using simple blood test calculations.

Thursday, April 9, 2026 0 views
Published in Cardiovasc Diabetol
A laboratory technician's hands holding two test tubes containing blood samples next to a digital glucose meter and HbA1c analyzer on a white lab bench

Summary

Researchers analyzed 8,942 Chinese adults aged 45+ over 9 years and found that the stress hyperglycemia ratio (SHR) - calculated from blood glucose and HbA1c levels - strongly predicts chronic disease risk. Higher SHR increased diabetes risk by 130%, hypertension by 30%, and liver disease by 65%. This simple calculation could help doctors identify high-risk patients early for preventive interventions.

Detailed Summary

A groundbreaking longitudinal study of 8,942 Chinese adults has revealed that a simple blood test calculation called the stress hyperglycemia ratio (SHR) can predict who will develop chronic diseases years before symptoms appear. The research, published in Cardiovascular Diabetology, followed participants for up to 9 years to track new disease onset.

SHR measures acute glucose dysregulation by dividing blood glucose levels by HbA1c values. Researchers found striking disease-specific associations: participants in the highest SHR quartile had a 130% increased risk of developing diabetes (HR=2.30, p<0.001), 30% higher risk of hypertension (HR=1.30, p<0.001), 43% greater risk of dyslipidemia (HR=1.43, p<0.001), and 65% elevated risk of liver disease (HR=1.65, p=0.002). Surprisingly, higher SHR correlated with 33% lower lung disease risk (HR=0.67, p=0.006).

The study used data from the China Health and Retirement Longitudinal Study, employing sophisticated statistical modeling including restricted cubic splines to detect nonlinear relationships. For diabetes specifically, researchers identified a nonlinear association, suggesting threshold effects where risk accelerates at certain SHR levels.

This research extends SHR's application beyond acute hospital settings, where it's already used to predict short-term outcomes in heart attacks and sepsis. The findings suggest SHR could become a valuable screening tool for chronic disease prevention, particularly valuable given its calculation requires only standard blood tests already performed in routine care. However, the study was limited to Chinese adults over 45, and diabetes diagnosis relied on self-reporting rather than laboratory confirmation.

Key Findings

  • Higher stress hyperglycemia ratio increased diabetes risk by 130% (HR=2.30, 95% CI: 1.82-2.91, p<0.001)
  • Elevated SHR raised hypertension risk by 30% (HR=1.30, 95% CI: 1.06-1.60, p<0.001)
  • Higher SHR increased dyslipidemia risk by 43% (HR=1.43, 95% CI: 1.17-1.74, p<0.001)
  • Elevated SHR raised liver disease risk by 65% (HR=1.65, 95% CI: 1.21-2.26, p=0.002)
  • Higher SHR unexpectedly reduced lung disease risk by 33% (HR=0.67, 95% CI: 0.50-0.89, p=0.006)
  • Study tracked 8,942 adults aged 45+ for up to 9 years across 14 different chronic conditions
  • Nonlinear relationship found between SHR and diabetes risk, suggesting threshold effects

Methodology

Prospective cohort study using China Health and Retirement Longitudinal Study data (2011-2020) with 8,942 participants aged ≥45 years. SHR calculated as glucose/(28.7×HbA1c%-46.7) from fasting blood samples. Cox proportional hazards models with restricted cubic splines assessed disease associations, adjusting for demographics, lifestyle factors, BMI, and baseline chronic conditions. Follow-up averaged 9 years with biennial assessments.

Study Limitations

Study limited to Chinese adults over 45, potentially limiting generalizability to other populations and younger adults. Diabetes diagnosis relied on self-reported physician diagnoses rather than laboratory confirmation, which may introduce misclassification bias. Researchers noted the need for validation studies in diverse populations and investigation of optimal SHR thresholds for clinical decision-making.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.